Procter Johnson Holdings Limited
Annual report and Financial Statements
For the year ended 31 December 2024
Procter Johnson Holdings Limited
Company information
Director
Mr H R Jackson
Company number
12023726
Registered office
The Glades
Festival Way
Festival Park
Stoke-on-Trent
Staffordshire
ST1 5SQ
Auditor
DJH Audit Limited
St George's House
56 Peter Street
Manchester
M2 3NQ
Business address
Excelsior Works
Castle Park
Flint
Clwyd
Wales
CH6 5NT
Procter Johnson Holdings Limited
Contents
Page
Strategic report
1 - 2
Director's report
3 - 4
Independent auditor's report
5 - 7
Group income statement
8
Group statement of comprehensive income
9
Group balance sheet
10
Company balance sheet
11
Group statement of changes in equity
12
Company statement of changes in equity
13
Group statement of cash flows
14
Notes to the financial statements
15 - 32
Procter Johnson Holdings Limited
Strategic report
For the year ended 31 December 2024
- 1 -
The director presents the strategic report for the year ended 31 December 2024.
Review of the business
Construction in the UK was slow in Q1, but improved through the summer. The general election in July, coupled with a cut in interest rates was expected to install confidence in the housing market. However, this is yet to materialise.
Raw material costs cooled slightly, which in turn lead to lower prices in the market. There were significant increases in sea freight during the summer months but this was short lived eventually getting back to usual levels in Q3.
The group continues to be audited to the following health & safety, quality and environmental standards, ISO45001, ISO9001 & ISO14001.
Principal risks and uncertainties
Price risk
The group operates in a highly competitive industry, which is subject to price pressure from both local and overseas competition. Overall, raw material costs & sea freight have remained steady throughout the year. Transit times from the Far East continue to be longer than previous years.
Increases in minimum wage and national insurance contributions are not helping with manufacturing costs.
Financial instrument risk
The business is exposed to the risk that financial instruments held by the group impact on its ability to operate effectively and profitably. The risks which are relevant to the group's operations are:
Currency risk
The group purchases many of its raw materials from overseas suppliers and as such, is often exposed to fluctuations in foreign exchange rates. The board reviews the impact movements in foreign exchange has on both imports and exports on an ongoing basis.
Credit risks
The group makes regular sales to existing customers which is considered to reduce credit risk. Policies are in place to ensure that provisions for bad debts are made when considered necessary.
Cashflow risks
The group carefully manages its stock holding and debtor book to ensure that sufficient cash is available to meet operational need. The group holds adequate cash balances and so it is not considered that cashflow issues are a significant risk to the group.
Liquidity risks
The group funds its working capital need through the generation and retention of profits. Management is confident that additional bank funding facilities would be available, should it be required, to fund working capital, further investment or any future expansion plans.
Development and performance
The group expects to meet budget for 2025, despite the slow housing market.
This is in line with our expectations when budgeting for the year.
The company will continue to expand its new product lines and also improve in production efficiencies to ensure that revenue and profitability is retained.
The new site in North Wales is now operational.
Procter Johnson Holdings Limited
Strategic report (continued)
For the year ended 31 December 2024
- 2 -
Key performance indicators
The board monitors progress of the company using the following KPIs:
Revenue
2024 2023
Revenue £19,399,426 £20,145,834
Increase (Decrease)% (3.7) (15.0)
This KPI is calculated by taking the turnover and other operating income for the year. This is compared to the previous year and movement is shown as a percentage
Operating Profit
2024 2023
Operating Profit £1,629,205 £1,708,319
% of revenue 8.7 8.5
This KPI is calculated by taking the total revenue and deducting, the cost of sales, distribution costs and administrative expenses.
Mr H R Jackson
Director
29 September 2025
Procter Johnson Holdings Limited
Director's report
For the year ended 31 December 2024
- 3 -
The director presents his annual report and financial statements for the year ended 31 December 2024.
Principal activities
The principal activity of the company in the period under review was that of a holding company.
The principal activity of the subsidiary undertaking is as follows:
P J Colours Limited - the manufacture and sale of pigments and additives to the concrete and asphalt industries.
Results and dividends
The results for the year are set out on page 8.
Ordinary dividends were paid amounting to £184,550. The director does not recommend payment of a further dividend.
Director
The director who held office during the year and up to the date of signature of the financial statements was as follows:
Mr H R Jackson
Research and development
The group invested in research and development in the year relating to product development.
Auditor
DJH Audit Limited, has indicated its willingness to continue in office and will be proposed for re-appointment in accordance with section 485 Companies Act 2006.
Statement of director's responsibilities
The director is responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Procter Johnson Holdings Limited
Director's report (continued)
For the year ended 31 December 2024
- 4 -
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
Disclosure in the strategic report
The company has chosen in accordance with section 414C(11) of Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 set out in company's Strategic Report information required by schedule 7 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008.
Medium company exemptions
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Mr H R Jackson
Director
29 September 2025
Procter Johnson Holdings Limited
Independent auditor's report
To the members of Procter Johnson Holdings Limited
- 5 -
Opinion
We have audited the financial statements of Procter Johnson Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2024 and of the group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The director is responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Procter Johnson Holdings Limited
Independent auditor's report (continued)
To the members of Procter Johnson Holdings Limited
- 6 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the director's report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the director's report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of director
As explained more fully in the director's responsibilities statement, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the director is responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the parent company or to cease operations, or has no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
The extent to which the audit was considered capable of detecting irregularities including fraud
Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:
- the engagement partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify or recognise non-compliance with applicable laws and regulations;
- we identified the laws and regulations applicable to the parent company and group through discussions with directors and other management;
- we focused on specific laws and regulations which we considered may have a direct material effect on the financial statements or the operations of the parent company and group, including legislation such as the Companies Act 2006, taxation legislation, data protection, employment, and health and safety legislation;
- we assessed the extent of compliance with the laws and regulations through making enquiries of management and reviewing legal and professional fee invoices.
Procter Johnson Holdings Limited
Independent auditor's report (continued)
To the members of Procter Johnson Holdings Limited
- 7 -
We assessed the susceptibility of the group financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:
- making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual, suspected and alleged fraud; and
- considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.
To address the risk of fraud through management bias and override of controls, we:
- performed analytical procedures to identify any unusual or unexpected relationships;
- tested journal entries posted during the period and at the period end to identify unusual transactions;
- investigated the rationale behind significant or unusual transactions; and
- performed walkthrough tests on major transaction cycles.
In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:
- agreeing financial statement disclosures to underlying supporting documentation;
- enquiring of management as to actual and potential litigation and claims;
- reviewing correspondence with HMRC; and
- reviewing legal and professional fees incurred during the period to identify any potential indications of non-compliance with laws and regulations.
There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.
Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Joanne Beamish ACA FCCA (Senior Statutory Auditor)
For and on behalf of DJH Audit Limited, Statutory Auditor
Accountants
St George's House
56 Peter Street
Manchester
M2 3NQ
29 September 2025
Procter Johnson Holdings Limited
Group profit and loss account
For the year ended 31 December 2024
- 8 -
2024
2023
Notes
£
£
Turnover
3
19,399,426
20,145,834
Cost of sales
(14,626,243)
(15,389,670)
Gross profit
4,773,183
4,756,164
Distribution costs
(751,841)
(755,685)
Administrative expenses
(2,404,019)
(2,544,081)
Other operating income
11,882
251,921
Operating profit
4
1,629,205
1,708,319
Interest receivable and similar income
7
23,591
17,472
Interest payable and similar expenses
8
(212,350)
(181,211)
Profit before taxation
1,440,446
1,544,580
Tax on profit
9
(378,798)
(368,187)
Profit for the financial year
24
1,061,648
1,176,393
Profit for the financial year is all attributable to the owners of the parent company.
Procter Johnson Holdings Limited
Group statement of comprehensive income
For the year ended 31 December 2024
- 9 -
2024
2023
£
£
Profit for the year
1,061,648
1,176,393
Other comprehensive income
-
-
Total comprehensive income for the year
1,061,648
1,176,393
Total comprehensive income for the year is all attributable to the owners of the parent company.
Procter Johnson Holdings Limited
Group balance sheet
As at 31 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
Tangible assets
12
4,262,306
3,760,658
4,262,306
3,760,658
Current assets
Stocks
15
3,261,633
2,580,694
Debtors
16
6,208,538
3,459,097
Cash at bank and in hand
448,215
524,813
9,918,386
6,564,604
Creditors: amounts falling due within one year
17
(6,178,025)
(3,502,830)
Net current assets
3,740,361
3,061,774
Total assets less current liabilities
8,002,667
6,822,432
Creditors: amounts falling due after more than one year
18
(1,953,065)
(1,701,807)
Provisions for liabilities
Deferred tax liability
21
296,609
244,730
(296,609)
(244,730)
Net assets
5,752,993
4,875,895
Capital and reserves
Called up share capital
23
1,111,120
1,111,120
Revaluation reserve
12,378
12,378
Profit and loss reserves
24
4,629,495
3,752,397
Total equity
5,752,993
4,875,895
These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.
The financial statements were approved and signed by the director and authorised for issue on 29 September 2025
29 September 2025
Mr H R Jackson
Director
Company registration number 12023726 (England and Wales)
Procter Johnson Holdings Limited
Company balance sheet
As at 31 December 2024
31 December 2024
- 11 -
2024
2023
Notes
£
£
£
£
Fixed assets
Investment property
2,600,575
2,600,575
Investments
13
2,233,341
2,233,341
4,833,916
4,833,916
Current assets
Debtors
16
882,585
1,244,926
Cash at bank and in hand
31,879
31,056
914,464
1,275,982
Creditors: amounts falling due within one year
17
(65,058)
(233,458)
Net current assets
849,406
1,042,524
Total assets less current liabilities
5,683,322
5,876,440
Creditors: amounts falling due after more than one year
18
(1,619,314)
(1,661,003)
Net assets
4,064,008
4,215,437
Capital and reserves
Called up share capital
23
1,111,120
1,111,120
Profit and loss reserves
24
2,952,888
3,104,317
Total equity
4,064,008
4,215,437
As permitted by s408 Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £33,121 (2023 - £1,612,675 profit).
The financial statements were approved and signed by the director and authorised for issue on 29 September 2025
29 September 2025
Mr H R Jackson
Director
Company registration number 12023726 (England and Wales)
Procter Johnson Holdings Limited
Group statement of changes in equity
For the year ended 31 December 2024
- 12 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 January 2023
1,111,120
12,378
2,784,384
3,907,882
Year ended 31 December 2023:
Profit and total comprehensive income
-
-
1,176,393
1,176,393
Dividends
11
-
-
(208,380)
(208,380)
Balance at 31 December 2023
1,111,120
12,378
3,752,397
4,875,895
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
1,061,648
1,061,648
Dividends
11
-
-
(184,550)
(184,550)
Balance at 31 December 2024
1,111,120
12,378
4,629,495
5,752,993
Procter Johnson Holdings Limited
Company statement of changes in equity
For the year ended 31 December 2024
- 13 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 January 2023
1,111,120
1,700,022
2,811,142
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
1,612,675
1,612,675
Dividends
11
-
(208,380)
(208,380)
Balance at 31 December 2023
1,111,120
3,104,317
4,215,437
Year ended 31 December 2024:
Profit and total comprehensive income
-
33,121
33,121
Dividends
11
-
(184,550)
(184,550)
Balance at 31 December 2024
1,111,120
2,952,888
4,064,008
Procter Johnson Holdings Limited
Group statement of cash flows
For the year ended 31 December 2024
- 14 -
2024
2023
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
30
677,687
4,697,106
Interest paid
(212,350)
(181,211)
Income taxes paid
(279,235)
(208,516)
Net cash inflow from operating activities
186,102
4,307,379
Investing activities
Purchase of tangible fixed assets
(721,257)
(1,070,271)
Proceeds from disposal of tangible fixed assets
913,300
-
Interest received
23,591
17,472
Net cash generated from/(used in) investing activities
215,634
(1,052,799)
Financing activities
Repayment of borrowings
-
(3,275,680)
Repayment of bank loans
(41,689)
(40,803)
Payment of finance leases obligations
(252,095)
(17,962)
Dividends paid to equity shareholders
(184,550)
(208,380)
Net cash used in financing activities
(478,334)
(3,542,825)
Net decrease in cash and cash equivalents
(76,598)
(288,245)
Cash and cash equivalents at beginning of year
524,813
813,058
Cash and cash equivalents at end of year
448,215
524,813
Procter Johnson Holdings Limited
Notes to the group financial statements
For the year ended 31 December 2024
- 15 -
1
Accounting policies
Company information
Procter Johnson Holdings Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is The Glades, Festival Way, Festival Park, Stoke-on-Trent, Staffordshire, United Kingdom, ST1 5TQ.
The group consists of Procter Johnson Holdings Limited and its subsidiary.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
1.2
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Procter Johnson Holdings Limited together with all entities controlled by the parent company (its subsidiaries).
All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 16 -
1.3
Going concern
At the time of approving the financial statements, the director has a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.
1.4
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
Straight line over 30 years
Leasehold improvements
Straight line over 15 years
Plant and equipment
33.33%, 20%, 10% and 5% on cost
Fixtures and fittings
25% on cost
Motor vehicles
33.33% on cost and 25% on reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
1.6
Investment properties
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Changes in fair value are recognised in profit or loss.
Property rented to a group entity is accounted for at fair value with changes in fair value recognised in profit or loss.
1.7
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 17 -
1.8
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.9
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined on the first-in, first-out (FIFO) method, and comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.10
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 18 -
1.11
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 19 -
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.12
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
1
Accounting policies
(Continued)
- 20 -
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.16
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
1.17
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
1.18
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.
Transactions between group entities which have been eliminated on consolidation are not disclosed within the financial statements.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 21 -
2
Judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Critical judgements
The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.
Property revaluation
Freehold property is measured using the revaluation model and as such requires significant judgement.
An external valuation has been undertaken at a date different to the year end. As such, directors judgements are required to determine the valuation of the freehold property at the year end. The directors judgements have been based on their knowledge of the freehold properties taking account of geographical locations, estimated rental values and the external valuation undertaken.
3
Turnover and other revenue
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
16,043,685
16,816,841
Rest of the world
3,355,741
3,328,993
19,399,426
20,145,834
2024
2023
£
£
Other revenue
Interest income
23,591
17,472
Sundry receipts
11,882
27,921
The turnover and profit before tax are attributable to the one principal activity of the group.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 22 -
4
Operating profit
2024
2023
£
£
Operating profit for the year is stated after charging/(crediting):
Exchange losses
18,773
33,039
Fees payable to the group's auditor for the audit of the group's financial statements
19,750
15,869
Depreciation of owned tangible fixed assets
166,206
82,384
Depreciation of tangible fixed assets held under finance leases
111,955
21,284
Profit on disposal of tangible fixed assets
(12,114)
-
Operating lease charges
338,225
275,500
5
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Directors
5
1
-
-
Employees
33
35
-
-
Total
38
36
0
0
Their aggregate remuneration comprised:
Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
1,365,083
1,243,646
Social security costs
114,490
100,050
-
-
Pension costs
135,549
133,902
1,615,122
1,477,598
6
Director's remuneration
2024
2023
£
£
Remuneration for qualifying services
8,060
16,859
Company pension contributions to defined contribution schemes
40,000
40,000
48,060
56,859
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
6
Director's remuneration
(Continued)
- 23 -
Money purchases schemes
The number of directors to whom retirement benefits were accruing was 1 (2022 - 1).
7
Interest receivable and similar income
2024
2023
£
£
Interest income
Interest on bank deposits
23,591
16,872
Other interest income
-
600
Total income
23,591
17,472
8
Interest payable and similar expenses
2024
2023
£
£
Interest on bank overdrafts and loans
125,305
111,676
Interest on invoice finance arrangements
60,102
65,673
Interest on finance leases and hire purchase contracts
25,804
3,862
Other interest
1,139
-
Total finance costs
212,350
181,211
9
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
326,919
159,678
Adjustments in respect of prior periods
(12,021)
Total current tax
326,919
147,657
Deferred tax
Origination and reversal of timing differences
51,879
220,530
Total tax charge
378,798
368,187
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
9
Taxation
(Continued)
- 24 -
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2024
2023
£
£
Profit before taxation
1,440,446
1,544,580
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 25.00%)
360,112
386,145
Tax effect of expenses that are not deductible in determining taxable profit
3,947
2,638
Permanent capital allowances in excess of depreciation
151
Depreciation on assets not qualifying for tax allowances
4,366
1,449
Adjustments in respect of financial assets
11,610
Tax at marginal rate
(1,237)
Under/over provision of tax in the year
(12,021)
Changes in tax rates
(10,202)
Underprovision of prior year deferred tax
-
27
Taxation charge
378,798
368,187
10
Individual income statement
As permitted by Section 408 of the Companies Act 2006, the Statement of Comprehensive Income of the parent company is not presented as part of these financial statements.
11
Dividends
2024
2023
Recognised as distributions to equity holders:
£
£
Interim paid
184,550
208,380
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 25 -
12
Tangible fixed assets
Group
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
£
Cost or valuation
At 1 January 2024
2,600,575
58,269
1,203,674
132,841
177,051
4,172,410
Additions
188,727
1,164,367
281,463
1,634,557
Disposals
(915,476)
(915,476)
At 31 December 2024
2,600,575
246,996
1,452,565
414,304
177,051
4,891,491
Depreciation and impairment
At 1 January 2024
749
286,046
29,961
94,996
411,752
Depreciation charged in the year
17,401
140,213
71,874
48,673
278,161
Eliminated in respect of disposals
(60,728)
(60,728)
At 31 December 2024
18,150
365,531
101,835
143,669
629,185
Carrying amount
At 31 December 2024
2,600,575
228,846
1,087,034
312,469
33,382
4,262,306
At 31 December 2023
2,600,575
57,520
917,628
102,880
82,055
3,760,658
The company had no tangible fixed assets at 31 December 2024 or 31 December 2023.
The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases or hire purchase contracts.
Group
Company
2024
2023
2024
2023
£
£
£
£
Plant and equipment
801,345
Motor vehicles
42,097
801,345
42,097
-
-
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
12
Tangible fixed assets
(Continued)
- 26 -
Freehold property, with a carrying amount of £2,600,575 (2023 - £2,600,575) are pledged as security against the bank loan included within creditors.
One of the two freehold properties was valued on 29 June 2021 by Matthews & Goodman LLP chartered surveyors and property consultants, at £395,000. The directors are of the view that there is no material difference between this valuation of the commercial property at 29 June 2021 and the fair value of freehold property held at 31 December 2024.
The second freehold property was purchased on 19 August 2021 for a total of £2,205,575. The directors are of the view that there is no material difference between the original cost price of this freehold property and the fair value of this property held at 31 December 2024.
The following assets are carried at valuation. If the assets were measured using the cost model, the carrying amounts would be as follows:
2024
2023
£
£
Group
Cost
382,326
382,326
Accumulated depreciation
(27,005)
(27,005)
Carrying value
355,321
355,321
13
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
14
2,233,341
2,233,341
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024 and 31 December 2024
2,233,341
Carrying amount
At 31 December 2024
2,233,341
At 31 December 2023
2,233,341
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 27 -
14
Subsidiaries
Details of the company's subsidiaries at 31 December 2024 are as follows:
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
PJ Colours Limited
The Glades, Festival Way, Festival Park, Stoke-On-Trent, Staffordshire, ST1 5SQ
Ordinary
100.00
15
Stocks
Group
Company
2024
2023
2024
2023
£
£
£
£
Raw materials and consumables
1,659,003
1,081,020
-
-
Finished goods and goods for resale
1,602,630
1,499,674
3,261,633
2,580,694
-
-
The total carrying amount of stock of £3,261,633 (2022 - £2,580,694) is pledged as security for the invoice finance account and loans included in creditors.
16
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
4,845,171
3,255,346
Amounts owed by group undertakings
-
-
882,585
1,244,926
Other debtors
1,246,120
61,754
Prepayments and accrued income
117,247
141,997
6,208,538
3,459,097
882,585
1,244,926
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 28 -
17
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans
19
39,068
39,068
39,068
39,068
Obligations under finance leases
20
405,059
36,801
Trade creditors
3,370,703
2,840,593
Corporation tax payable
100,222
52,538
9,391
26,086
Other taxation and social security
201,960
183,323
-
-
Other creditors
1,757,480
168,304
16,599
168,304
Accruals and deferred income
303,533
182,203
6,178,025
3,502,830
65,058
233,458
Included within other creditors is an amount of £1,740,881 relating to the invoice discounting facility, which is secured by way of a debenture incorporating a first legal mortgage and first fixed charge over the assets of the company.
18
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Bank loans
19
1,619,314
1,661,003
1,619,314
1,661,003
Obligations under finance leases
20
333,751
40,804
1,953,065
1,701,807
1,619,314
1,661,003
19
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Bank loans
1,658,382
1,700,071
1,658,382
1,700,071
Payable within one year
39,068
39,068
39,068
39,068
Payable after one year
1,619,314
1,661,003
1,619,314
1,661,003
The bank loan is secured on the property purchased, along with the existing land and buildings owned by the group.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 29 -
20
Finance lease obligations
Group
Company
2024
2023
2024
2023
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
405,059
36,801
In two to five years
333,751
40,804
738,810
77,605
-
-
Finance lease payments represent rentals payable by the company for company motor vehicles and plant and machinery. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
The hire purchase creditor is secured by the assets to which it relates.
21
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
Liabilities
Liabilities
2024
2023
Group
£
£
Accelerated capital allowances
296,609
244,730
The company has no deferred tax assets or liabilities.
Group
Company
2024
2024
Movements in the year:
£
£
Liability at 1 January 2024
244,730
-
Charge to profit or loss
51,879
-
Liability at 31 December 2024
296,609
-
22
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
135,549
133,902
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
22
Retirement benefit schemes
(Continued)
- 30 -
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
23
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares A of £1 each
666,672
666,672
666,672
666,672
Ordinary shares B of £1 each
388,892
388,892
388,892
388,892
Ordinary shares C of £1 each
27,778
27,778
27,778
27,778
Ordinary shares D of £1 each
27,778
27,778
27,778
27,778
1,111,120
1,111,120
1,111,120
1,111,120
Each Ordinary share has full voting rights, the right to receive dividends and the right to participate in a capital distribution on a sale or winding up. They do not confer any rights of redemption.
24
Profit and loss reserves
Group
Company
2024
2023
2024
2023
£
£
£
£
At the beginning of the year
3,752,397
2,784,384
3,104,317
1,700,022
Profit for the year
1,061,648
1,176,393
33,121
1,612,675
Dividends
(184,550)
(208,380)
(184,550)
(208,380)
At the end of the year
4,629,495
3,752,397
2,952,888
3,104,317
Retained earnings comprises accumulated profits less any losses and distributions which have been retained within the company. This is a distributable reserve.
Revaluation reserve represents gains on revaluation of property owned by the company, less any revaluation losses and provisions for deferred tax on the revaluation. This is a non-distributable reserve.
There is no tax arising on the movements in the revaluation reserve.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 31 -
25
Operating lease commitments
Lessee
At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
978
46,999
-
-
Between two and five years
44,054
53,244
-
-
45,032
100,243
-
-
26
Events after the reporting date
After the year end, a legal charge was registered dated 9 May 2025 by HSBC Invoice Finance (UK) Limited, having a fixed and floating charge over the assets of the company.
28
Directors' transactions
Dividends totalling £37,400 (2023 - £0) were paid in the year in respect of shares held by the company's directors.
Interest free loans have been granted by the group to its directors as follows:
Description
% Rate
Opening balance
Amounts advanced
Closing balance
£
£
£
Mr H R Jackson - Directors' loan account
-
-
1,228,745
1,228,745
-
1,228,745
1,228,745
29
Ultimate controlling party
The controlling party is H R Jackson.
Procter Johnson Holdings Limited
Notes to the group financial statements (continued)
For the year ended 31 December 2024
- 32 -
30
Cash generated from group operations
2024
2023
£
£
Profit after taxation
1,061,648
1,176,393
Adjustments for:
Taxation charged
378,798
368,187
Finance costs
212,350
181,211
Investment income
(23,591)
(17,472)
Gain on disposal of tangible fixed assets
(12,114)
-
Depreciation and impairment of tangible fixed assets
278,161
103,668
Movements in working capital:
(Increase)/decrease in stocks
(680,939)
2,800,463
(Increase)/decrease in debtors
(2,749,441)
1,257,313
Increase/(decrease) in creditors
2,212,815
(1,172,657)
Cash generated from operations
677,687
4,697,106
31
Analysis of changes in net debt - group
1 January 2024
Cash flows
New finance leases
31 December 2024
£
£
£
£
Cash at bank and in hand
524,813
(76,598)
-
448,215
Borrowings excluding overdrafts
(1,700,071)
41,689
-
(1,658,382)
Obligations under finance leases
(77,605)
252,095
(913,300)
(738,810)
(1,252,863)
217,186
(913,300)
(1,948,977)
2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.200Mr H R Jacksonfalse120237262024-01-012024-12-3112023726bus:Director12024-01-012024-12-3112023726bus:RegisteredOffice2024-01-012024-12-3112023726bus:Consolidated2024-12-3112023726bus:Consolidated2024-01-012024-12-3112023726bus:Consolidated2023-01-012023-12-31120237262023-01-012023-12-31120237262024-12-3112023726bus:Consolidated2023-12-3112023726core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-12-3112023726core:LeaseholdImprovementsbus:Consolidated2024-12-3112023726core:PlantMachinerybus:Consolidated2024-12-3112023726core:FurnitureFittingsbus:Consolidated2024-12-3112023726core:MotorVehiclesbus:Consolidated2024-12-3112023726core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3112023726core:LeaseholdImprovementsbus:Consolidated2023-12-3112023726core:PlantMachinerybus:Consolidated2023-12-3112023726core:FurnitureFittingsbus:Consolidated2023-12-3112023726core:MotorVehiclesbus:Consolidated2023-12-31120237262023-12-3112023726core:ShareCapitalbus:Consolidated2024-12-3112023726core:ShareCapitalbus:Consolidated2023-12-3112023726core:RevaluationReservebus:Consolidated2024-12-3112023726core:RevaluationReservebus:Consolidated2023-12-3112023726bus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2024-12-3112023726core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3112023726core:AccountingPolicyChangeIncreaseDecrease2023-12-3112023726core:ShareCapital2024-12-3112023726core:ShareCapital2023-12-3112023726core:RetainedEarningsAccumulatedLosses2024-12-3112023726core:RetainedEarningsAccumulatedLosses2023-12-3112023726core:ShareCapitalbus:Consolidated2022-12-3112023726core:SharePremiumbus:Consolidated2022-12-31120237262022-12-3112023726core:RetainedEarningsAccumulatedLossesbus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2024-12-3112023726core:AccountingPolicyChangeIncreaseDecrease2024-12-3112023726core:ShareCapital2022-12-3112023726core:RetainedEarningsAccumulatedLosses2022-12-3112023726core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3112023726bus:Consolidated2022-12-3112023726core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3112023726core:LeaseholdImprovements2024-01-012024-12-3112023726core:PlantMachinery2024-01-012024-12-3112023726core:FurnitureFittings2024-01-012024-12-3112023726core:MotorVehicles2024-01-012024-12-3112023726core:UKTaxbus:Consolidated2024-01-012024-12-3112023726core:UKTaxbus:Consolidated2023-01-012023-12-3112023726bus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2024-01-012024-12-3112023726bus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2023-01-012023-12-3112023726bus:Consolidated12024-01-012024-12-3112023726bus:Consolidated12023-01-012023-12-3112023726bus:Consolidated22024-01-012024-12-3112023726bus:Consolidated22023-01-012023-12-3112023726bus:Consolidated32024-01-012024-12-3112023726bus:Consolidated32023-01-012023-12-3112023726bus:Consolidated42024-01-012024-12-3112023726bus:Consolidated42023-01-012023-12-3112023726core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3112023726core:LeaseholdImprovementsbus:Consolidated2023-12-3112023726core:PlantMachinerybus:Consolidated2023-12-3112023726core:FurnitureFittingsbus:Consolidated2023-12-3112023726core:MotorVehiclesbus:Consolidated2023-12-3112023726bus:Consolidated2023-12-3112023726core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-01-012024-12-3112023726core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3112023726core:PlantMachinerybus:Consolidated2024-01-012024-12-3112023726core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3112023726core:MotorVehiclesbus:Consolidated2024-01-012024-12-3112023726core:PlantMachinery2024-12-3112023726core:PlantMachinery2023-12-3112023726core:MotorVehicles2024-12-3112023726core:MotorVehicles2023-12-3112023726core:Subsidiary12024-01-012024-12-3112023726core:Subsidiary112024-01-012024-12-3112023726core:CurrentFinancialInstruments2024-12-3112023726core:CurrentFinancialInstruments2023-12-3112023726core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3112023726core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3112023726core:WithinOneYearbus:Consolidated2024-12-3112023726core:WithinOneYearbus:Consolidated2023-12-3112023726core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3112023726core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3112023726core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3112023726core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3112023726core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3112023726core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3112023726core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3112023726core:Non-currentFinancialInstrumentsbus:Consolidated2023-12-3112023726core:Non-currentFinancialInstruments2024-12-3112023726core:Non-currentFinancialInstruments2023-12-3112023726core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3112023726core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3112023726core:WithinOneYear2024-12-3112023726core:WithinOneYear2023-12-3112023726core:BetweenTwoFiveYearsbus:Consolidated2024-12-3112023726core:BetweenTwoFiveYearsbus:Consolidated2023-12-3112023726core:BetweenTwoFiveYears2024-12-3112023726core:BetweenTwoFiveYears2023-12-3112023726bus:PrivateLimitedCompanyLtd2024-01-012024-12-3112023726bus:FRS1022024-01-012024-12-3112023726bus:Audited2024-01-012024-12-3112023726bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3112023726bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP